Cemiplimab Storage and Handling Guide

　　1.Drug Overview

　　Cemiplimab is a PD-1 immune checkpoint inhibitor administered via intravenous infusion,indicated for the treatment of certain advanced skin cancers(such as cutaneous squamous cell carcinoma)and non-small cell lung cancer(NSCLC).As a monoclonal antibody biologic,its protein structure is sensitive to environmental conditions,making proper storage essential for maintaining drug stability and therapeutic effectiveness.

　　2.Appearance and Formulation

　　Cemiplimab injection typically presents as a clear to slightly opalescent solution,ranging in color from colorless to pale yellow.In some cases,small translucent to white particles may be observed,which is a normal occurrence for certain biologic products.The drug is supplied in single-dose vials,with a common specification of 350 mg/7 mL(50 mg/mL concentration),intended for single-use intravenous infusion.

　　3.Core Storage Conditions

　　Per the prescribing information,Cemiplimab must be stored in a refrigerator at 2°C to 8°C(36°F to 46°F)and should not be kept at room temperature for extended periods.During storage,the following principles must be strictly observed:protect from direct sunlight to prevent UV-induced protein damage,and never freeze the product,as freezing can alter the antibody's three-dimensional conformation,causing protein aggregation or degradation that compromises drug quality and safety.

　　4.Transport and Handling Precautions

　　During storage and transport,vigorous shaking of Cemiplimab injection must be avoided.As an antibody-based biologic,intense agitation may promote intermolecular interactions leading to aggregate formation,which can affect solution uniformity and stability.If drug transport is required,the entire cold-chain process must maintain temperatures within the 2°C to 8°C range,with appropriate temperature monitoring in place.

　　5.Pre-Use Visual Inspection

　　Before drug withdrawal,the solution should be carefully inspected for any significant changes in appearance.Abnormalities to watch for include noticeable color changes,large amounts of precipitate,marked cloudiness,or any other deviation from normal appearance.If any such abnormalities are detected,the product should not be used,and a pharmacist or healthcare professional should be consulted.

　　6.Patient Information

　　For patients,Cemiplimab is typically stored and administered by hospitals or specialized healthcare facilities;home storage by individuals is uncommon.Patients should attend scheduled appointments at designated medical centers for intravenous infusion and do not need to manage drug storage independently.In rare cases where drug transfer is necessary,the cold chain must remain unbroken,and guidance from qualified professionals should be followed.

　　7.Summary

　　Cemiplimab,as a biologic agent,has stringent storage requirements:refrigerated storage at 2°C to 8°C is recommended,freezing is strictly prohibited,light exposure should be avoided,and agitation should be minimized.Adhering to these storage conditions is fundamental to ensuring drug efficacy and patient safety.